1.An experimental study about how edaravone affect the nerve cells apoptosis in the compressed spinal cord
Bo GAO ; Mingyan DONG ; Xuyuan DING ; Yulin LIU ; Guoxi WANG ; Wenju FU ; Yang GUO ; Guanghai SUN
Journal of Chinese Physician 2017;19(4):514-517
Objective To investigate the protective function of edaravone in the compressed spinal cord.Methods There were 150 rabbits enrolled in each group in the experiment.Rabbits in both operation group and edaravone (EDA) treating group received mild spinal cord compressionby setting a flap head screw between C6 C7 after the neck.The spinal cord decompression was conducted seven days later.After 6 hours,rabbits in the EDA treating group were injected with a large amount of EDA through ear border veins,while the rabbits in the operation group only received 0.9% sodium chloride injection.The transmission electron microscope was used to observe the apoptotic bodies at 1 day,3 days and 7 days after compression,and 1 day,3 days,7 days,and 14 days after decompression.Flow cytometry was used to test the rate of apoptosis of spinal cord cells.Immunohistochemistry was used to test the expression of Bax protein that is related to apoptosis.Results The neuronal apoptosis appeared after compression in both operation group and EDA-treating group.The Basso Beattie Bresnahan (BBB) score,neuronal apoptosis rates,and Bax protein expressions in both groups were statistically different (P < 0.05) when the spinal cord was compressed in the first day and the third day,while there was no statistically different when spinal cord compressed at the seventh day (P > 0.05).After decompression of the spinal cord,the BBB score,neuronal apoptosis rates,and Bax protein expressions in both groups were becoming lower at the seventh day (P <0.05).Conclusions EDA has protective function for compressed spinal cord.However,only the compression of spinal cord compression period of sufficient decompression can fundamentally protect the spinal cord.
2.Study on fingerprint of Mulberry leaves by GC-MS.
Lian SUN ; Wenju YANG ; Long LIU
China Journal of Chinese Materia Medica 2009;34(7):879-883
OBJECTIVETo establish a GC-MS fingerprint profile of the volatile oil in mulberry leaves (dried leaves of Morus abla) in order to provide the referent basis of quality evaluation.
METHODThe volatile oil was extracted from mulberry leaves by water stream distillation method, 10 bathes of samples collected from different regions were analyzed by GC-MS, and their GC-MS fingerprint were subsequently established. Hierarchical clustering analysis was performed by SPSS software.
RESULTSeventeen common characteristic peaks were summarized from the fingerprint of the 10 baths of mulberry Leaves sample, which were clasified two categories by the result of hierarchical clustering analysis, namely samples collected in Akesu area, Tulufan area, Hami area, Hetian Loupu county, Jiangsu province, Sichuang province, Shanxi province and Guangzhou were in a group, whereas those from Yili area and Wulumqi were in another group.
CONCLUSIONThe established GC-MS fingerprint could be used for the identification and quality evaluation of mulberry leaves, the method was accurate and reliable, the fingerprint was intuitive and specific.
Gas Chromatography-Mass Spectrometry ; Morus ; chemistry ; Oils, Volatile ; analysis ; chemistry ; isolation & purification ; Plant Leaves ; chemistry ; Reproducibility of Results
3.Bone morphogenetic protein 2 expression in rabbit radial defect site with different lengths
Yulin ZHAN ; Zhiquan AN ; Luyuan SUN ; Changqing ZHANG ; Bingfang ZENG ; Feng XU ; Guozhu HOU ; Wenju LI ; Xiaomeng ZHU ; Xinghua SONG
Chinese Journal of Tissue Engineering Research 2013;(30):5511-5517
BACKGROUND:It has been studied that the distribution of bone morphogenetic protein 2 is regular under bone defect situation. OBJECTIVE:To observe the expression of bone morphogenetic protein 2 in rabbit radial defect site with different lengths. METHODS:Forty-eight New Zealand rabbits were divided into two groups randomly, 0.5 cm bone defect and 3.0 cm bone defect were made by wire saw at the middle part of radius bone after anaesthesia. RESULTS AND CONCLUSION:Western blot results showed that in the 0.5 cm bone defect group, the expression of bone morphogenetic protein 2 of the tissues in the bone defect site was increased gradual y at 1, 3, 4 weeks after operation, and the expression in each defect group was increased when compared with that immediately after injury (P<0.05). In the 3.0 cm bone defect group, the expression of bone morphogenetic protein 2 of tissues in bone defect site was increased gradual y and reached to its peak at 3 weeks after the operation (P<0.05), and the peak value in the 3.0 cm bone defect group was significantly higher than that in 0.5 cm bone defect group (P<0.05). The peak value was maintained in high level. The comparison of bone cal us formation showed that the bone cal us formation of 3.0 cm bone defect group was less than that of the 0.5 cm bone defect group at 3 and 4 weeks after operation (P<0.05). The results indicate that expression of the bone morphogenetic protein 2 in 3.0 cm bone defect site is increased significantly, but the expression level cannot make the bone defect heal itself.
4.Application value of volumetric modulated arc therapy combined with zoledronic acid in treatment of vertebral metastasis
Wenju SUN ; Chengyu SHI ; Xiaoyan MA ; Yuan YAO
Cancer Research and Clinic 2018;30(11):735-738
Objective To investigate the application value of volumetric modulated arc therapy (VMAT) combined with zoledronic acid in treatment of vertebral metastases. Methods A total of 58 patients with vertebral metastasis in Qingdao Central Hospital from January 2015 to June 2017 were extracted according to simple random sampling method. The data of 58 patients were analyzed retrospectively, and they were divided into 2 groups according to the different radiotherapy technology. The study group (28 cases) received VMAT combined with zoledronic acid treatment, and the control group (30 cases) received general radiotherapy combined with zoledronic acid treatment. The efficacy and tissue damage of the patients in both groups were compared according to the evaluation criterion including the local control rate, pain relief rate, local progression-free survival rate and exposure of the spinal cord. Results The local control rates were 92.9 % (26/28) and 73.3 % (22/30) respectively in the study group and the control group (χ2= 3.869, P=0.049). The pain relief rates were 96.4 % (27/28) and 76.7 % (23/30) respectively (χ2= 4.757, P= 0.029). The local progression-free survival rates of 3-month were 85.7 % (24/28), 60.0 % (18/30) respectively (χ2=4.794, P= 0.029) and the local progression-free survival rates of 6-month were 78.6 % (22/28), 50.0 %(15/30) in the study group and the control group (χ2=5.119, P=0.024). The exposure of the spinal cord was (29.80±0.88) Gy and (39.90±0.20) Gy, respectively (t= -61.083, P= 0.000). Conclusion VMAT combined with zoledronic acid can improve the local control rate, pain relief rate, local progression-free survival rate, and reduce the exposure of the spinal cord.
5. Analysis of needlestick injuries and depression among the female medical staff in a city district in 2018
Wenju YUAN ; Ligeng SUN ; Zhi WANG
Chinese Journal of Industrial Hygiene and Occupational Diseases 2019;37(6):443-445
Objective:
To investigate needlestick injuries and depression among the female medical staff in a city district.
Methods:
Using cross-sectional survey methods, female medical staff from selected sixteen hospitals voluntarily participated in questionnaire survey on APP of mobile phone. They Data were uploaded assessment platform, saved by Excel, and analysed by SPSS 22.0 statistical software.
Results:
The lasted year, Incidence of needlestick injuries was 11.28%. Incidence of needlestick injuries was respectively 5.2%, 9.1% and 16.3% in Class-I hospital, Second-class Hospital and three levels of hospitals(χ2=28.900,